Table 2.
Comparison of Patients With Progressive or Recurrent Tumors Who Underwent Repeat Surgery and Patients Who Did Not
| Variable | Overall (n = 43) | Repeat Surgery (n = 21) | No Repeat Surgery (n = 22) | P-value |
|---|---|---|---|---|
| Age, median (IQR) | 44.5 (52.9–35.5) | 44.3 (32.1–51.2) | 46.7 (38.0–54.9) | .24 |
| Sex, n (%) | 26 (60.5%) | 16 (76.2%) | 10 (45.5%) | .06 |
| Frontal location, n (%) | 31 (72.0%) | 17 (18.0%) | 14 (63.6%) | .31 |
| Eloquence, n (%)** | 19 (46.3%) | 8 (40.0%) | 11 (52.4%) | .43 |
| Chemotherapy, n (%)* | 31 (72.1%) | 16 (51.6%) | 15 (48.4%) | .74 |
| Radiation therapy, n (%)* | 19 (44.2%) | 9 (47.4%) | 10 (52.6%) | .99 |
IQR, interquartile range.
*Refers to chemotherapy and radiation therapy received after progression/recurrence.
**2 cases do not have data available on eloquence.